Xyall
Automated tissue dissection system for global rollout.
About
Xyall is a MedTech startup focused on developing and deploying an automated tissue dissection system. The company has secured significant funding for its global expansion.
Similar companies
Developing wearable brain imaging systems using quantum sensing technology.
Shares Medical Devices, Biotechnology
Redefining kidney stone treatment with an aspiration-based stone removal system.
Shares Medical Devices, HealthTech
Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
Shares Medical Devices, Biotechnology
Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.
Shares Medical Devices, HealthTech
Developing a minimally invasive, one-time outpatient therapy for obesity treatment.
Shares Medical Devices, Biotechnology
Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.
Shares Medical Devices, HealthTech
Key facts
- Headquarters
- Eindhoven, North Brabant, Netherlands
- Total funding
- $8M (Unknown)
- Business model
- B2B
Frequently asked
How much funding has Xyall raised?
Xyall has raised a total of $8M in funding. The most recent round on record is Unknown.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Xyall
